Anthony Clarke
CIK 1713368 · CSO · last filed 2022-04-29
Anthony Clarke is a CSO who has filed 10 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for ACHV, was dated Apr 29, 2022. Current disclosed insider exposure totals $30.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$30.1K
2
10
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACHV | CSO | 4,634 | $6.50 | $30.1K | $0 | 9 | 2022-04-29 |
| ACHIEVE LIFE SCIENCES, INC. (OGXI) Delisted | Chief Scientific Officer | 10,607,225 | — | — | $0 | 1 | 2017-08-03 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-29 | ACHV | Mixed | +750 | -$1.9K | EDGAR |
| 2022-01-10 | ACHV | Grant (A) | — | $0 | EDGAR |
| 2021-01-28 | ACHV | Grant (A) | — | $0 | EDGAR |
| 2020-11-18 | ACHV | Grant (A) | — | $0 | EDGAR |
| 2020-01-30 | ACHV | Grant (A) | — | $0 | EDGAR |
| 2019-01-31 | ACHV | Grant (A) | — | $0 | EDGAR |
| 2018-09-21 | ACHV | Grant (A) | — | $0 | EDGAR |
| 2018-07-30 | ACHV | Grant (A) | — | $0 | EDGAR |
| 2017-08-11 | ACHV | Grant (A) | +1,625,136 | $0 | EDGAR |
| 2017-08-03 | ACHIEVE LIFE SCIENCES, INC. (OGXI) Delisted | Grant (A) | +16,971,560 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.